Log in to save to my catalogue

Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated wi...

Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated wi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f7bbd7e52767460db7aae6e9fd368504

Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated with monoclonal antibodies against COVID‐19: A case report

About this item

Full title

Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated with monoclonal antibodies against COVID‐19: A case report

Publisher

England: John Wiley & Sons, Inc

Journal title

Clinical case reports, 2023-01, Vol.11 (1), p.e6776-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Common variable immunodeficiency (CVID) is the most prevalent primary immunodeficiency. We present a 22‐year‐old Caucasian woman with CVID and granulomatous lymphocytic interstitial lung disease who contracted COVID‐19 and was successfully treated with sotrovimab and molnupiravir. This treatment may have contributed to the relatively mild disease c...

Alternative Titles

Full title

Common variable immunodeficiency with granulomatous‐lymphocytic interstitial lung disease treated with monoclonal antibodies against COVID‐19: A case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f7bbd7e52767460db7aae6e9fd368504

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f7bbd7e52767460db7aae6e9fd368504

Other Identifiers

ISSN

2050-0904

E-ISSN

2050-0904

DOI

10.1002/ccr3.6776

How to access this item